Sandesh Mahatme

CIK 1511034 · CFO · last filed 2026-06-09

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$585.1K

Companies

5

Total Filings

49

Lifetime Open-Market Net

-$50.71M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CRSP Director $49.80 $0 3 2026-06-09
VOR CFO 0 $14.36 $0 $0 2 2025-12-09
Spyre Therapeutics, Inc. (AGLE) Delisted Director $12.01 $0 7 2022-06-09
SRPT EVP, CFO & CBO 30,851 $15.31 $472.3K -$50.71M 29 2020-07-09
FLXN Director 4,500 $25.05 $112.7K $0 8 2020-06-12

Recent Filings · Page 5 of 5

49 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2016-05-19 Spyre Therapeutics, Inc. (AGLE) Delisted Grant (A) $0 EDGAR
2016-03-02 SRPT Grant (A) +3,115 $0 EDGAR
2015-06-19 FLXN Grant (A) $0 EDGAR
2015-03-03 SRPT Grant (A) $0 EDGAR
2014-07-24 FLXN Grant (A) $0 EDGAR
2014-03-04 SRPT Grant (A) $0 EDGAR
2013-08-20 SRPT Buy (P) +5,000 $155.5K EDGAR
2013-06-07 SRPT Grant (A) $0 EDGAR
2012-11-07 SRPT Grant (A) $0 EDGAR
Showing 4149 of 49
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.